Sisram Medical Ltd — Director's Dealing 2021

Oct 7, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Sisram Medical Ltd * 復 銳 醫療科技有限公司

(Incorporated in Israel with limited liability)

(Stock Code: 1696)

VOLUNTARY ANNOUNCEMENT

PURCHASE OF SHARES IN THE COMPANY BY THE CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR

This announcement is made by Sisram Medical Ltd (the “ Company ”) on a voluntary basis.

The Company has been informed by Mr. Lior Moshe DAYAN (“ Mr. DAYAN ”), the Chief Executive Officer and an Executive Director of the Company, that on 6 October 2021, Mr. DAYAN made on-market purchases on The Stock Exchange of Hong Kong Limited of an aggregate of 25,000 shares in the Company (“ Shares ”) at a purchase price of HK$11.045 per Share. As at 6 October 2021, Mr. DAYAN was interested in an aggregate of 138,500 Shares, representing approximately 0.030% of the issued share capital of the Company.

By Order of the Board Sisram Medical Ltd Yi LIU Chairman

Hong Kong, 7 October 2021

As at the date of this announcement, the board of directors of the Company comprises Mr. Yi LIU, Mr. Lior Moshe DAYAN and Mr. Guojun BU as executive directors; Mr. Yifang WU, Mr. Yao WANG and Ms. Rongli FENG as non-executive directors; Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN and Mr. Kai Yu Kenneth LIU as independent non-executive directors.

• for identification purpose only